Mifepristone (RU 486) registered for use in Australia

Parliament house flag post

Mifepristone (RU 486) registered for use in Australia

Posted 31/08/2012 by Amanda Biggs

Australian Government - Department of Health - Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA), the regulator of medicines and therapeutic devices in Australia, has announced that from 29 August 2012 the abortifacient mifepristone (RU 486) will be listed on the Australian Register of Therapeutic Goods (ARTG). Misoprostol, a drug that can be used in conjunction with mifepristone but already available in Australia, has also been approved for use in medical abortion. Medical abortion is a method of pregnancy termination that involves the administration of a drug or drugs to induce an abortion, and is distinct from surgical abortion.

The approval of mifepristone follows the successful application by Marie Stopes International Australia (Marie Stopes), a national provider of sexual health and family planning services, to have it registered for pregnancy termination. Registration on the ARTG means that mifepristone is now allowed to be marketed and sold in Australia, although potential prescribers must still abide by the laws on abortion in their jurisdiction.

Since 2006, when a Ministerial veto on its use in Australia was lifted (for background, see this Parliamentary library publication), mifepristone has only been available through the TGA’s Authorised Prescriber Scheme. Under the Authorised Prescriber Scheme a medical practitioner who wants to prescribe mifepristone must apply to the TGA for permission to import the drug and is required to administer it under strict conditions and with ethical oversight.

Prior to 2006, mifepristone was classified as a ‘restricted good’ which could only be imported into Australia with written Ministerial approval. While not a direct ban, this restriction effectively discouraged potential sponsors from seeking approval, as it ensured any application to import the drug would attract considerable political attention. With the passage of the Therapeutic Goods Amendment (Repeal of Ministerial responsibility for approval of RU486) Bill 2005 (see the Bills Digest for details), the Ministerial authority to approve the importation of mifepristone was removed. This meant that in line with other drug approvals it was the responsibility of the TGA to assess the efficacy, safety and quality of mifepristone if any application for registration was made.

However, at the time Ministerial authority was removed no sponsor undertook to apply for registration of mifepristone, so it remained accessible only through the Authorised Prescriber Scheme. It has been suggested that the small size of the Australian market, the political history surrounding the drug and Australia’s abortion laws have contributed to sponsor reluctance. As of August 2012, 187 medical practitioners had obtained authorisation to prescribe mifepristone for pregnancy termination. Listing on the ARTG according to the TGA statement, means that medical termination will now be available to a wider group of Australian women.

Mifepristone has been approved for use in a number of countries, including the United Kingdom, the United States, much of Western Europe, Russia, China, Israel, New Zealand, Turkey and Tunisia. It works by blocking the effects of the hormone progesterone, which is crucial to starting and maintaining pregnancy. The prostaglandin misoprostol is then administered, which induces uterine contractions and results in the expulsion of the contents of the uterus. Mifepristone is mainly administered in the first trimester of pregnancy; the TGA has approved its use in the first 7 weeks of pregnancy.

While termination using mifepristone is generally regarded as being a safe procedure, the death of an Australian woman from sepsis in 2010 who was prescribed the drug did raise some questions over patient care. Data from South Australia, which is one of the few jurisdictions that mandates reporting of abortion statistics, reports the complication rate for the 669 mifepristone/misoprostol induced terminations undertaken in 2010, was 5.2 per cent (mainly due to the contents of the uterus being retained). This rate of complication was higher than for surgical abortion (0.5 per cent), but lower than for other medical methods (administration of other prostaglandins orally or vaginally). According to the TGA statement, since going onto the Authorised Provider Scheme, 792 reports of adverse events associated with mifepristone have been provided to the TGA (and one recorded death due to sepsis).

As the sponsor, Marie Stopes has undertaken to include a tailored educational package for medical practitioners who seek to prescribe mifepristone. Only those medical practitioners who have completed appropriate training as approved by Marie Stopes will be able to prescribe and administer the drug (although Fellows and Diploma holders of the Royal Australian and New Zealand College of Obstetricians and Gyneacologists will not have to complete the training). Supply of mifepristone will also be provided through Marie Stopes. The registration of mifepristone is also conditional upon the sponsor undertaking a post marketing study that must include the reporting of any serious adverse events associated with mifepristone such as retained products, bleeding and infection.

Listing on the ARTG does not mean the drug automatically goes onto the subsidised medicine list, the Pharmaceutical Benefits Scheme (PBS). A separate application for listing must be made to the independent evaluator, the Pharmaceutical Benefits Advisory Committee. News media have reported that Marie Stopes is considering applying for a PBS listing.

The listing of mifepristone is likely to remain controversial, given its past history in Australia and the ongoing opposition to abortion among a proportion of the Australian population. Reports of any adverse events associated with its wider availability will be scrutinised, as will the role of the TGA in overseeing its safety and efficacy. Whether it’s listing on the ARTG will have broader impacts, including on the legal status of abortion in the states and territories, may depend on it establishing a record of safety and efficacy.


  • 3/05/2015 7:53 PM

Thank you for your comment. If it does not require moderation, it will appear shortly.
Facebook LinkedIn Twitter Add | Email Print


Flagpost is a blog on current issues of interest to members of the Australian Parliament

Parliamentary Library Logo showing Information Analysis & Advice




refugees asylum immigration Australian foreign policy Parliament climate change elections women social security Indigenous Australians Australian Bureau of Statistics Employment Sport illicit drugs people trafficking taxation Medicare welfare reform Australian Defence Force higher education welfare policy United Nations Asia income management Middle East criminal law disability Australian Sports Anti-Doping Agency World Anti-Doping Agency United States federal budget health financing gambling school education forced labour aid statistics Australian Electoral Commission WADA emissions trading Australia in the Asian Century steroids detention Private health insurance OECD ASADA labour force transport Law Enforcement Australian Federal Police Industrial Relations people smuggling dental health National Disability Insurance Scheme Australian Crime Commission slavery Senate election results Papua New Guinea Australian Public Service International Women's Day corruption Afghanistan Fair Work Act child protection debt federal election 2013 parliamentary procedure poker machines ALP New Zealand Newstart Parenting Payment 43rd Parliament political parties Census constitution High Court skilled migration voting Federal Court terrorist groups Higher Education Loan Program HECS youth paid parental leave Aviation environment foreign debt gross debt net debt defence capability customs doping health crime health risks multiculturalism aged care Gonski Review of Funding for Schooling sex slavery sea farers Special Rapporteur leadership United Kingdom UK Parliament Electoral reform politics banking firearms public policy violence against women domestic violence mental health China ADRV terrorism social media pensions welfare ASIO intelligence community Australian Security Intelligence Organisation governance public service reform Carbon Pricing Mechanism carbon tax mining military history employer employee fishing by-election European Union same sex relationships international relations coal seam gas family assistance planning United Nations Security Council Australian economy food vocational education and training Drugs Indonesia children codes of conduct terrorist financing money laundering Productivity asylum seekers early childhood education Canada Population Financial sector national security fuel disability employment Tasmania integrity science research and development Australian Secret Intelligence Service sexual abuse federal state relations World Trade Organization Australia accountability housing affordability bulk billing water renewable energy children's health health policy Governor-General US economy export liquefied natural gas foreign bribery question time speaker superannuation expertise Senators and Members climate Intergovernmental Panel on Climate Change Department of Agriculture Fisheries and Forestry food labelling Pacific Islands reserved seats new psychoactive substances synthetic drugs UNODC carbon markets health reform Indigenous constitutional recognition of local government local government consumer laws PISA royal commission US politics language education baby bonus Leaders of the Opposition Parliamentary remuneration health system Australia Greens servitude Trafficking Protocol energy forced marriage rural and regional Northern Territory Emergency Response ministries social citizenship human rights citizenship Defence High Court; Indigenous; Indigenous Australians; Native Title ACT Indigenous education Norfolk Island External Territories emissions reduction fund; climate change child care funding refugees immigration asylum procurement Indigenous health e-voting internet voting nsw state elections 44th Parliament 2015 ABS Age Pension Death penalty capital punishment execution Bali nine Bali bombings Trade EU China soft power education Fiji India Disability Support Pension Antarctica Diplomacy by-elections state and territories workers Bills anti-corruption fraud bribery transparency corporate ownership whistleblower G20 economic reform innovation standards NATO Members of Parliament Scottish referendum Middle East; national security; terrorism social services Criminal Code Amendment (Misrepresentation of Age to a Minor) Bill 2013 online grooming sexual assault of minors ACT Assembly public health smoking plain packaging tobacco cigarettes Asia; Japan; international relations Work Health and Safety Migration; asylum seekers; regional processing China; United States; international relations fiscal policy Racial Discrimination Act; social policy; human rights; indigenous Australians Foreign policy Southeast Asia Israel Palestine regional unemployment asylum refugees immigration political finance donations foreign aid Economics efficiency human rights; Racial Discrimination Act employment law bullying Animal law; food copyright Australian Law Reform Commission industry peace keeping contracts workplace policies trade unions same-sex marriage disorderly conduct retirement Parliament House standing orders public housing prime ministers election timetable sitting days First speech defence budget submarines Somalia GDP forestry world heritage political engagement leave loading Trade; tariffs; safeguards; Anti-dumping public interest disclosure whistleblowing Productivity Commission regulation limitation period universities Ireland cancer gene patents genetic testing suspension of standing and sessional orders animal health live exports welfare systems infant mortality middle class welfare honorary citizen railways disciplinary tribunals standard of proof World Health Organisation arts international students skilled graduate visas temporary employment visas apologies roads Italy national heritage NHMRC nutrition anti-dumping Constitutional reform referendum Rent Assistance competition policy pharmaceutical benefits scheme obesity evidence law sacrament of confession US presidential election international days DFAT UN General Assembly deregulation Regulation Impact Statements administrative law small business Breaker Morant homelessness regional engagement social determinants of health abortion Youth Allowance Members suspension citizen engagement policymaking federal election 2010 workplace health and safety Trafficking in Persons Report marine reserves hearing TAFE Victoria astronomy resources sector YMCA youth parliament alcohol Korea rebate Australian Greens presidential nomination Racial Discrimination Act entitlements political parties preselection solar hot water Financial Action Taskforce Horn of Africa peacekeeping piracy Great Barrier Reef Stronger futures political financing Hung Parliament political education social inclusion Social Inclusion Board maritime early childhood National Quality Framework for Early Childhood Education and Care Murray-Darling Basin Iran sanctions Norway hospitals

Show all
Show less
Back to top